ITM
ITM Isotopen Technologien München AG
Trademark Registered: 2021-06-15
Trademark Application Details
NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79295820 |
| Registration Number | 6383044 |
| Mark Drawing Code | 3000: Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) |
Timeline
| 2020-07-28 | Application Filed |
| 2020-10-15 | Location: INITIAL REVIEW/SERIALIZATION BRANCH(MAILROOM) |
| 2020-10-15 | Status: Live/Pending |
| 2020-10-19 | Transaction Date |
| 2021-06-15 | Trademark Registered |
Trademark Applicants & Owners
| Owner: |  ITM Isotopen Technologien München AG |
| Address | Lichtenbergstr. 1 85748 Garching DE |
| Legal Entity Type | Aktiengesellschaft (ag) |
| Legal Entity State | DE |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Design Search Codes
| 260113 | Circles, two (not concentric); Two circles |
| 260121 | Circles that are totally or partially shaded. |
| 270301 | Geometric figures forming letters, numerals or punctuation |
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| International Codes: | 10 |
| U.S. Codes: | 026,039,044 |
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| International Codes: | 44 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| GS0051 | Radiopharmaceutical diagnostic and therapeutic preparations for medical purposes, in particular radiopharmaceutical preparations for endo-radionuclide therapy, brachytherapy and radiopharmaceutical preparations for positron emission tomography [PET] or single photon emission tomography [SPECT], target radionuclide and peptide receptor radionuclide therapy [PRRT]; theranostics in the field of precision oncology; radiopharmaceutical products, namely, lutetium-containing precursors; solutions for radioactive labelling; radiopharmaceutical preparations for use in oncology, namely, radiopharmaceuticals containing radioisotopes, e.g. lutetium-177, actinium-225, yttrium-90 for treatment and radioisotopes such as gallium-68 or fluorine-18 for diagnosis of tumours; target radiopharmaceuticals containing a target molecule, e.g. peptide or antibody, depending on the indication and a medical radioactive isotope; radiopharmaceuticals containing gallium and its complexes, gallium-68 DOTATOC; 177Lu-edotreotide preparations for targeted radionuclide therapy in patients with neuroendocrine tumours of gastroenteric or pancreatic origin [GEP-NET]; radiopharmaceuticals for use in the therapy of GEP-NET, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer; radiopharmaceuticals containing radioisotopes with short half-lives, such as gallium-68 or fluorine-18 for diagnostic applications; Radiopharmaceuticals for use with highly sensitive molecular imaging technologies such as PET [positron emission tomography] or SPECT [single photon emission tomography], for the production of images of organs and lesions and for the early diagnosis of diseases; radiopharmaceuticals containing medical radioisotopes with longer half-lives, in particular lutetium-177, actinium-225 or yttrium-90 for the treatment of tumour diseases |
| DM0000 | The mark consists of "ITM" in stylized form with two circles emanating from the left corner of the "I" in "ITM" at a diagonal. |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2020-10-15 | 1 REPR M: |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2020-10-19 | 2 NWOS I:Incoming Correspondence |
| APPLICATION FILING RECEIPT MAILED | 2020-10-23 | 3 MAFR O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2020-11-16 | 4 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2020-11-19 | 5 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2020-11-20 | 6 RFCR E:E-Mail |
| REFUSAL PROCESSED BY MPU | 2020-12-08 | 7 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2020-12-08 | 8 RFCS P: |
| REFUSAL PROCESSED BY IB | 2020-12-27 | 9 RFNT P: |
| TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2021-02-12 | 10 TROA I:Incoming Correspondence |
| CORRESPONDENCE RECEIVED IN LAW OFFICE | 2021-02-12 | 11 CRFA I:Incoming Correspondence |
| TEAS/EMAIL CORRESPONDENCE ENTERED | 2021-02-14 | 12 TEME I:Incoming Correspondence |
| TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2021-02-12 | 13 COAR I:Incoming Correspondence |
| TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2021-02-12 | 14 REAP I:Incoming Correspondence |
| ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2021-02-12 | 15 ARAA I:Incoming Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2021-02-12 | 16 TCCA I:Incoming Correspondence |
| APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2021-02-12 | 17 CHAN I:Incoming Correspondence |
| EXAMINERS AMENDMENT -WRITTEN | 2021-02-23 | 18 CNEA R:Renewal |
| EXAMINERS AMENDMENT E-MAILED | 2021-02-23 | 19 GNEA O:Outgoing Correspondence |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2021-02-23 | 20 GNEN O:Outgoing Correspondence |
| EXAMINER'S AMENDMENT ENTERED | 2021-02-23 | 21 XAEC I:Incoming Correspondence |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2021-02-23 | 22 CNSA O:Outgoing Correspondence |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2021-03-10 | 23 NONP E:E-Mail |
| NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | 2021-03-10 | 24 OP2R P: |
| NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2021-03-15 | 25 OPNS P: |
| PUBLISHED FOR OPPOSITION | 2021-03-30 | 26 PUBO A:Allowance for Publication |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2021-03-30 | 27 NPUB E:E-Mail |
| NOTIFICATION PROCESSED BY IB | 2021-04-05 | 28 GPNX P: |
| REGISTERED-PRINCIPAL REGISTER | 2021-06-15 | 29 R.PR A:Allowance for Publication |
| FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2021-09-15 | 30 FICR P: |
| GENERIC MADRID TRANSACTION CREATED | 2021-09-30 | 31 XXCR P: |
| GENERIC MADRID TRANSACTION SENT TO IB | 2021-09-30 | 32 XXSS O:Outgoing Correspondence |
| NEW REPRESENTATIVE AT IB RECEIVED | 2021-10-21 | 33 NREP P: |
| FINAL DECISION TRANSACTION PROCESSED BY IB | 2021-11-15 | 34 FINO P: |
| CHANGE OF NAME/ADDRESS REC'D FROM IB | 2021-11-26 | 35 ADCH M: |
Similar Marks
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 